טוען...
Transfection of hPSC-Cardiomyocytes Using Viafect™ Transfection Reagent
Twenty years since their first derivation, human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) have shown promise in disease modelling research, while their potential for cardiac repair is being investigated. However, low transfection efficiency is a barrier to wider realisation of the pot...
שמור ב:
| הוצא לאור ב: | Methods Protoc |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
MDPI
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7564709/ https://ncbi.nlm.nih.gov/pubmed/32784848 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/mps3030057 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|